The CFHR1 gene helps control the complement system, a part of your immune system that needs to attack germs without harming your own tissues. This gene plays an important role in keeping that response balanced. If the CFHR1 gene is missing or not working as expected, this balance can shift and may contribute to kidney disease and rare immune conditions, including atypical hemolytic uremic syndrome. Some CFHR1 changes are also linked to differences in the chance of age related macular degeneration.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the information needed to make proteins, the working parts of cells. Others mainly regulate when certain processes happen, where they take place, and how strongly they run. Together, genes affect how your body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
CFHR1Gene function
What if the gene works
The CFHR1 gene helps control part of the immune system called complement. Its protein helps keep inflammation and tissue damage in check by fine tuning how complement proteins act in the blood and on cell surfaces.
Risk
What if the gene does not work
Changes in the CFHR1 gene can disturb complement control and are linked to kidney conditions such as atypical hemolytic uremic syndrome and C3 glomerulopathy. Milder or more severe variants can affect whether symptoms appear and how strong they are.
Treatment
What does that mean for your treatment
No CFHR1-specific treatment or drug choice is currently established. In related complement-mediated kidney conditions, treatment is guided by the clinical diagnosis and complement findings, not by CFHR1 status alone. CFHR1 loss, especially the CFHR3-CFHR1 deletion, is mainly studied as a biomarker linked to anti-factor H autoantibody associated atypical hemolytic uremic syndrome.
Conditions associated with CFHR1
Gene function
What if the gene works
Your immune system needs careful control so it can mark germs and damaged material without spreading too far. The CFHR1 gene helps make a protein that circulates in the blood and works within the complement system, part of your body’s rapid defense network. In everyday immune defense, it helps guide where this response acts and how strongly it develops.
The protein from the CFHR1 gene helps control the complement system, a fast acting part of immune defense. It helps keep this response measured so tagging and cleanup stay in balance.
Its protein can attach to surfaces already marked by complement proteins. This helps focus immune activity where it is needed instead of letting it spread more widely.
This protein also interacts with proteins that drive later complement steps. By shaping these steps, it supports a more controlled immune reaction in the bloodstream.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body reacts to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes how a gene works more significantly and can contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFHR1 gene can reduce how much protein is made, change its shape, or remove it entirely, which can weaken its binding to immune proteins in the blood. How CFHR1 variants affect protein function ranges from milder changes with partial activity to more severe variants, including gene deletions, that leave little or no working protein. These changes can have stronger effects on complement balance and, in linked kidney conditions, may be tied to earlier or more marked disease.
How variants are linked to conditions
Variants and deletions in the CFHR1 gene are linked to several conditions, mainly atypical hemolytic uremic syndrome and C3 glomerulopathy. The common CFHR3-CFHR1 deletion has also been associated with a lower risk of age-related macular degeneration in population studies. These conditions linked to CFHR1 gene variants depend on the exact change, and common variants influence risk rather than guarantee illness.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific day-to-day factors that clearly increase or reduce risk related to CFHR1 itself. Some CFHR1 changes are linked with certain kidney or eye conditions, but overall risk can also depend on other genes and immune system factors.
Inheritance of CFHR1 variants
There is not yet a single broadly confirmed Mendelian pattern that explains how variants of the CFHR1 gene are inherited across all CFHR1-related findings, because many reported changes act more as risk factors than as a stand-alone genetic diagnosis. In practice, how variants of the CFHR1 gene are inherited can be more complex than a simple dominant or recessive pattern. The CFHR1 gene is located on chromosome 1, which is an autosome, so you inherit one copy from each parent.
What does my CFHR1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a single, specific condition for CFHR1, and different CFHR1 changes may have different family implications. If you have a specific CFHR1 result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the CFHR1 gene is usually done on a blood or saliva sample. A lab reads the DNA sequence or checks for a missing copy, so CFHR1 genetic testing can find changes linked to some kidney and immune related conditions. Results are interpreted alongside your symptoms and other lab findings.
When should I consider getting a genetic test?
Genetic testing for the CFHR1 gene may be considered if someone has repeated episodes of a rare kidney problem called atypical hemolytic uremic syndrome, or related signs of uncontrolled inflammation in the kidneys. It can also make sense when this kind of kidney disease runs in the family or when blood tests suggest the body is attacking a kidney-protecting protein.
A genetic result is only one part of your health story
A genetic result can be very informative, although what it can tell you varies depending on the condition and the kind of variant involved. Lifestyle, environment, age, and medical history all influence how the body functions as time goes on. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside the rest of a person’s care. In other situations, the result may provide a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug, which can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that focuses on how genetic differences affect a person’s response to medications. It examines links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. More information on this topic is available in the LearnHub.
Drugs influenced by the CFHR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. For CFHR1, research has looked at whether changes affecting the body’s complement system may relate to response to complement-targeting treatments in rare kidney and blood conditions, but this is not used routinely to choose medicines.
History
The CFHR1 gene entered medical genetics through research on a cluster of closely related genes on chromosome 1 that drew attention in the late 1990s and early 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, some inherited kidney and immune conditions were gradually linked to changes around CFHR1. Researchers then noticed that a missing copy of the CFHR1 gene could appear in healthy people but was also linked to certain patterns of autoimmune kidney disease. From these first observations, research expanded steadily. Studies of CFHR1 also helped clarify how larger deletions involving nearby genes can shape risk differently across conditions, including rare kidney diseases and age related macular degeneration.